MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.numecd.2023.08.011

Медицинская библиотека · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2023

Patient-reported muscle symptoms and their characterization in a hypertensive population eligible for statin therapy: An exploratory study.

Sarzani Riccardo, Allevi Massimiliano, Giulietti Federico, Sarnari Silvia, Scorcella Samuele, Di Agostini Angelica, Turri Paolo, Di Pentima Chiara, Spannella Francesco

Наблюдательное исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Statin-associated muscle symptoms (SAMS) are claimed to be frequent in clinical practice. We evaluated the prevalence and characteristics of patient-reported muscle symptoms (PRMS) attributed to drugs/nutraceuticals in hypertensive patients, focusing the attention on statin treatment.

METHODS AND

RESULTS

Observational study on 390 consecutive outpatients. All patients were asked the following question: "Have you ever taken a drug/nutraceutical that you think gave you muscle symptoms?". Patients who answered "yes" were evaluated with a modified version of the SAMS-clinical index (SAMS-CI). Mean age: 60.5 ± 13.5 years (males 53.8%.). Patients who have ever taken a statin: 250. Patients who have never taken a statin: 140. Prevalence of PRMS (48.5% of the entire study population) did not differ between groups (p = 0.217). Only age, followed by number of drugs taken, was significantly associated with PRMS at multivariate analysis. A high prevalence of low scores to all the questions of "modified" SAMS-CI was found in both groups. Localization and pattern of PRMS did not differ between groups (p = 0.170). Timing of PRMS onset after starting the drug (p = 0.036) and timing of improvement after withdrawal (p = 0.002) were associated with statin therapy.

CONCLUSION

PRMS are highly prevalent among the hypertensive population and are believed to be drug-related, especially with aging and regardless of whether the drug taken is a statin or not. These findings are in line with the growing evidence that subjective muscle symptoms are often misattributed to statins, while they may more likely be related to the nocebo/drucebo effect or to other common undiagnosed conditions.

Для цитирования: Sarzani Riccardo, Allevi Massimiliano, Giulietti Federico, Sarnari Silvia, Scorcella Samuele, Di Agostini Angelica, Turri Paolo, Di Pentima Chiara, Spannella Francesco. Patient-reported muscle symptoms and their characterization in a hypertensive population eligible for statin therapy: An exploratory study.. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2023. DOI: 10.1016/j.numecd.2023.08.011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.